When do you start losing weight on Wegovy — and what does the evidence actually show?

What STEP 1 showed about the pace of loss, week by week

The STEP 1 trial is the foundational evidence for semaglutide 2.4mg in weight management. Over 68 weeks, adults without diabetes lost an average of approximately 15% of their starting body weight. That figure sounds clean, but the trajectory matters more than the end point if you're trying to understand when results actually arrive.

Weight loss in STEP 1 was not linear. Participants were titrated slowly upward, spending four weeks at each of four dose steps before reaching 2.4mg. During those early months, the scale moved, but gently. The sharpest rate of loss tracked closely with dose increases. By around week 12 to 16, when most participants had reached 1mg or 1.7mg, weekly losses became more consistent. The steepest cumulative decline appeared between roughly weeks 16 and 44.

That pattern has a practical implication: if you're in your first few weeks and the change feels small, you're probably in the part of the curve where the dose hasn't fully built yet. Slow early progress isn't a sign the medicine isn't working; it's the design of the schedule. Understanding when Wegovy's weight-loss effects kick in is easier once you know that dose level, not time alone, drives the rate. If you want a closer look at the numbers behind that curve, our guide on when you start losing weight on Wegovy walks through what typical timelines actually look like.

For a plain-English summary of how semaglutide works in the body, the NHS semaglutide medicines page is a reliable starting point.

The first pen: what to expect at 0.25mg and 0.5mg

The first four weeks on Wegovy are often described by patients as the settling-in phase. At 0.25mg (the licensed starting point) appetite suppression exists but is generally subtle. Many people notice they feel full faster at meals or lose interest in snacking before they see any movement on the scales.

Some people do lose weight at 0.25mg. Others see very little shift and wonder whether the medicine is working at all. Both experiences are within the normal range. The 0.25mg dose exists to let the body adjust to the GI effects of semaglutide, nausea, loose stools and discomfort are common early on, and starting low reduces how intense those effects tend to be. Weight loss at this stage is a bonus, not the goal.

At 0.5mg (weeks five to eight for most people), appetite reduction tends to become more noticeable. This is where a meaningful number of patients first feel the behavioural shift, smaller portions feeling satisfying, less urgency around food. Scale change often follows a week or two behind the appetite change, because the body is still adapting. That slight lag catches people out, but it's expected.

If you're weighing yourself daily during this period, you'll likely see natural fluctuation that obscures the trend. Weekly weigh-ins, same time, same conditions, give a cleaner picture, the kind of practical detail that our clinical team routinely shares with patients starting out.

Doses 1mg to 2.4mg: where most of the weight loss happens

By the time titration reaches 1mg and then 1.7mg, most people are experiencing Wegovy's appetite-suppressing effects at a level that genuinely changes how much they eat day to day. This is the phase where weight loss on Wegovy tends to become consistent enough to feel real, typically somewhere between months two and four of treatment, depending on how quickly the dose steps go.

Reaching the 2.4mg maintenance dose is the point the STEP 1 trial evidence is built around. Some people get there in around four months; others titrate more slowly if they're managing side effects. The 7.2mg dose (the higher maintenance option the MHRA approved in 2026) is intended for people who need additional effect after establishing on 2.4mg. Trial data for 7.2mg reported approximately 20.7% average weight loss over 72 weeks, approaching tirzepatide's results in longer studies. You can read about semaglutide's clinical background for more on how the different doses compare.

The practical upshot: most of the total weight lost on Wegovy arrives after month four. Early months are real progress, they're just the foundation rather than the bulk of the result. Staying consistent through the titration phase is what the later losses depend on. Information on when semaglutide's effects on weight tend to build covers this in more detail if you want a deeper look.

What affects your personal timeline

Two people can follow the same schedule and have quite different experiences by week 16. Biology explains most of it: metabolic rate, gut hormone sensitivity, how severely appetite is suppressed, and how much body weight is being lost as fat versus lean mass all vary between individuals. None of those factors can be predicted from the outside.

What does make a consistent difference in the evidence is what happens alongside the injection. Wegovy is licensed for use with a reduced-calorie diet and increased physical activity, the STEP 1 participants received lifestyle support throughout the trial, and real-world results that include strong dietary and activity habits tend to track closer to the trial figures than those without them. Protein adequacy matters particularly: when weight loss is fast, protecting muscle mass through adequate protein and some resistance activity is the kind of practical advice prescribers give early.

Adherence to the schedule matters too. Missing doses or reducing the dose to manage side effects both slow the timeline. That's not a reason to push through discomfort, it's a reason to stay in contact with your clinical team so adjustments can be made properly. For context on what the full treatment involves, our weight-loss treatment overview covers the broader approach, and there's a cost overview for Wegovy if you're at the stage of working out whether private treatment is practical for you. If you'd like a prescriber to assess your suitability, you can start a free consultation, a real clinician reviews your information the same day.